✦ LIBER ✦

Patterns of antibodies to hepatitis C virus in patients with chronic non-A, non-B hepatitis and their relationship to viral replication and liver disease

✍ Scribed by Liliana Chemello; Daniela Cavalletto; Patrizia Pontisso; Flavia Bortolotti; Carlo Donada; Valter Donadon; Mario Frezza; Pietro Casarin; Dr. Alfredo Alberti

Publisher: John Wiley and Sons
Year: 1993
Tongue: English
Weight: 490 KB
Volume: 17
Category: Article
ISSN: 0270-9139
DOI: 10.1002/hep.1840170203

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Chronic liver disease and cirrhosis amon

Chronic liver disease and cirrhosis among patients with hepatitis B virus infection in northern Portugal with reference to the viral genotypes

✍ Ana Mota; Jorge Areias; Margarida Fonseca Cardoso 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 85 KB 👁 2 views

## Abstract The prevalence of infection with hepatitis B virus in Portugal is around 1% of the population; 20–30% of those infected typically develop cirrhosis. The study focuses on the epidemiological profile of patients with hepatitis B infection and liver damage, in particular, cirrhosis. Of the

Susceptibility to hepatitis A in patient

Susceptibility to hepatitis A in patients with chronic liver disease due to hepatitis C virus infection: Missed opportunities for vaccination

✍ Michael Shim; Inessa Khaykis; James Park; Edmund J. Bini 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 207 KB 👁 2 views

Hepatitis A virus (HAV) superinfection is associated with a high risk of liver failure and death in patients with underlying chronic liver disease. Although HAV vaccination is recommended for all patients with chronic hepatitis C virus (HCV) infection, little is known about adherence to these recomm

Prevalence of hepatitis B, C, and D viru

Prevalence of hepatitis B, C, and D virus markers in yemeni patients with chronic liver disease

✍ Abdulkader M. El Guneid; Abdalla A. Gunaid; Ann Marie O'Neill; Nael I. Zureikat; 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 434 KB 👁 1 views

## Abstract A serological survey for hepatitis B, C, and D markers was carried out in the Yemen Republic. Serum samples from 243 pregnant females, 294 male blood donors, and 108 patients with chronic liver disease were examined. Hepatitis B surface antigen (HBsAg) was found in 18.5% healthy individ

Relationship of the genomic complexity o

Relationship of the genomic complexity of hepatitis C virus with liver disease severity and response to interferon in patients with chronic HCV genotype 1b interferon

✍ Francesc-Xavier López-Labrador; Sergi Ampurdanès; Mireia Giménez-Barcons; Magdal 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 124 KB 👁 3 views

In patients with chronic hepatitis C, the influence of the genetic heterogeneity of the hepatitis C virus (HCV) on the progression of liver disease and on the responsiveness to interferon therapy is a matter of controversy. In this study we evaluated the genetic complexity of HCV by singlestrand con

Severity of liver disease in liver trans

Severity of liver disease in liver transplantation recipients with hepatitis C virus infection: Relationship to genotype and level of viremia

✍ S Zhou; N A Terrault; L Ferrell; J A Hahn; J Y Lau; P Simmonds; J P Roberts; J R 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 187 KB 👁 1 views

vival, and patient survival. We conclude that HCV geno-Infection with hepatitis C virus (HCV) genotype 1b type 1 and subtype 1b are not associated with disease has been reported to be associated with more severe severity or graft survival in liver transplantation recipiposttransplantation liver dise

Combined treatment with interferon alpha

Combined treatment with interferon alpha-2b and ribavirin for chronic hepatitis C in patients with a previous non-response or non-sustained response to interferon alone

✍ R. Schvarcz; Z. B. Yun; A. Sönnerborg; O. Weiland 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 442 KB 👁 2 views

Ten patients with chronic hepatitis C, six of whom had not responded and four of whom had responded in a non-sustained fashion to interferon-alpha treatment alone, were given interferon alpha-2b and ribavirin in combination during 24 weeks. Interferon alpha-2b was given subcutaneously, at a dose of